SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-001069
Filing Date
2024-02-13
Accepted
2024-02-13 16:20:49
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20231231x10q.htm   iXBRL 10-Q 1380938
2 EX-31.1 rzlt-20231231xex31d1.htm EX-31.1 15331
3 EX-32.1 rzlt-20231231xex32d1.htm EX-32.1 7373
  Complete submission text file 0001558370-24-001069.txt   6976730

Data Files

Seq Description Document Type Size
4 EX-101.SCH rzlt-20231231.xsd EX-101.SCH 48613
5 EX-101.CAL rzlt-20231231_cal.xml EX-101.CAL 38654
6 EX-101.DEF rzlt-20231231_def.xml EX-101.DEF 223385
7 EX-101.LAB rzlt-20231231_lab.xml EX-101.LAB 356312
8 EX-101.PRE rzlt-20231231_pre.xml EX-101.PRE 365595
77 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20231231x10q_htm.xml XML 1314072
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 24626308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)